Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP992588.RAa6khzPrmXlXrLyA66eN0L0CxBcfmhPpb-g6serOqPNY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP992588.RAa6khzPrmXlXrLyA66eN0L0CxBcfmhPpb-g6serOqPNY130_assertion type Assertion NP992588.RAa6khzPrmXlXrLyA66eN0L0CxBcfmhPpb-g6serOqPNY130_head.
- NP992588.RAa6khzPrmXlXrLyA66eN0L0CxBcfmhPpb-g6serOqPNY130_assertion description "[Our data showed that a common pattern of microRNA expression distinguishes any tumor type from normal pancreas, suggesting that this set of microRNAs might be involved in pancreatic tumorigenesis; the expression of miR-103 and miR-107, associated with lack of expression of miR-155, discriminates tumors from normal; a set of 10 microRNAs distinguishes endocrine from acinar tumors and is possibly associated with either normal endocrine differentiation or endocrine tumorigenesis; miR-204 is primarily expressed in insulinomas and correlates with immunohistochemical expression of insulin; and the overexpression of miR-21 is strongly associated with both a high Ki67 proliferation index and presence of liver metastasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP992588.RAa6khzPrmXlXrLyA66eN0L0CxBcfmhPpb-g6serOqPNY130_provenance.
- NP992588.RAa6khzPrmXlXrLyA66eN0L0CxBcfmhPpb-g6serOqPNY130_assertion evidence source_evidence_literature NP992588.RAa6khzPrmXlXrLyA66eN0L0CxBcfmhPpb-g6serOqPNY130_provenance.
- NP992588.RAa6khzPrmXlXrLyA66eN0L0CxBcfmhPpb-g6serOqPNY130_assertion SIO_000772 16966691 NP992588.RAa6khzPrmXlXrLyA66eN0L0CxBcfmhPpb-g6serOqPNY130_provenance.
- NP992588.RAa6khzPrmXlXrLyA66eN0L0CxBcfmhPpb-g6serOqPNY130_assertion wasDerivedFrom befree-20150227 NP992588.RAa6khzPrmXlXrLyA66eN0L0CxBcfmhPpb-g6serOqPNY130_provenance.
- NP992588.RAa6khzPrmXlXrLyA66eN0L0CxBcfmhPpb-g6serOqPNY130_assertion wasGeneratedBy ECO_0000203 NP992588.RAa6khzPrmXlXrLyA66eN0L0CxBcfmhPpb-g6serOqPNY130_provenance.